Feedback / Questions
SOL-257 - SOLA Biosci
https://www.businesswire.com/news/home/20231109597814/en/SOLA-Biosciences-Presents-Preclinical-Proof-of-Concept-Data-for-SOL-257-a-Gene-Therapy-Targeting-Misfolded-TDP-43-in-ALS-at-Neuroscience-2023-and-ALS-One-Symposium
Nov 10, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next